Anemia in cirrhosis: An underestimated entity

Table 2 Ongoing trials on evaluation and management of anemia in cirrhosis

S No	Trial name	Clinical Trials.gov identifier	Aim	Ref.
1	Etiopathogenesis of anemia in chronic liver disease	NCT04622449	(1) To determine the prevalence of various etiologies of anemia in patients with liver disease; and (2) Association of liver disease severity as measured by MELD, MELD Na and CTP scores with severity of anemia	Premkumar[62]
2	Iron deficiency anemia in children with liver cirrhosis	NCT03482076	To determine prevalence of IDA in liver cirrhosis	Mohamed[63]
3	Lactoferrin in treatment of Fe deficiency anemia in cirrhosis	NCT04335058	(1) Correction of anemia (time frame: 1 mo): Number of participants achieving hemoglobin level > 12 g/dL iron deficiency anemia in patients with chronic liver disease of any etiology; and (2) Correction of anemia (time frame: 3 mo): Number of participants achieving hemoglobin level > 12 g/dL	Premkumar[64]

MELD: Model for end-stage liver disease; CTP: Child Turcotte Pugh score; IDA: Iron deficiency anemia.